Antidepressant-Related Signaling Pathways of Zinc Oxide Nanoparticles in a Mouse Model of Postpartum Depression

Key Points

• Zinc oxide nanoparticles show significant antidepressant effects in the mouse model of postpartum depression, indicating a potential new treatment.
• The study observed a reduction in depressive symptoms using biochemical signaling measurements, with notable pathway activation.
• This analysis employs a mouse model to explore how zinc oxide nanoparticles interact with antidepressant signaling pathways.
• These findings may enable novel therapeutic strategies for postpartum depression—but require further validation in human studies.